Bifogade filer
Kurs
+8,00%
Likviditet
0,03 MSEK
Kalender
Tid* | ||
2025-02-27 | 08:00 | Bokslutskommuniké 2024 |
2024-12-05 | - | Split POLAR 300:1 |
2024-11-29 | - | Kvartalsrapport 2024-Q3 |
2024-11-19 | - | Extra Bolagsstämma 2024 |
2024-08-30 | - | Kvartalsrapport 2024-Q2 |
2024-05-31 | - | Kvartalsrapport 2024-Q1 |
2024-05-29 | - | X-dag ordinarie utdelning POLAR 0.00 SEK |
2024-05-28 | - | Årsstämma |
2024-02-23 | - | Bokslutskommuniké 2023 |
2023-11-24 | - | Kvartalsrapport 2023-Q3 |
2023-09-08 | - | Extra Bolagsstämma 2023 |
2023-08-25 | - | Kvartalsrapport 2023-Q2 |
2023-05-26 | - | Kvartalsrapport 2023-Q1 |
2023-05-17 | - | Årsstämma |
2023-05-05 | - | X-dag ordinarie utdelning POLAR 0.00 SEK |
2023-03-13 | - | Extra Bolagsstämma 2022 |
2023-02-24 | - | Bokslutskommuniké 2022 |
2022-11-25 | - | Kvartalsrapport 2022-Q3 |
2022-08-26 | - | Kvartalsrapport 2022-Q2 |
2022-05-27 | - | Kvartalsrapport 2022-Q1 |
2022-05-06 | - | X-dag ordinarie utdelning POLAR 0.00 SEK |
2022-05-05 | - | Årsstämma |
2022-02-25 | - | Bokslutskommuniké 2021 |
2021-11-26 | - | Kvartalsrapport 2021-Q3 |
2021-08-27 | - | Kvartalsrapport 2021-Q2 |
2021-05-28 | - | Kvartalsrapport 2021-Q1 |
2021-05-06 | - | X-dag ordinarie utdelning POLAR 0.00 SEK |
2021-05-05 | - | Årsstämma |
2021-02-26 | - | Bokslutskommuniké 2020 |
2020-11-27 | - | Kvartalsrapport 2020-Q3 |
2020-08-28 | - | Kvartalsrapport 2020-Q2 |
2020-07-01 | - | X-dag ordinarie utdelning POLAR 0.00 SEK |
2020-06-30 | - | Årsstämma |
2020-05-29 | - | Kvartalsrapport 2020-Q1 |
2020-02-28 | - | Bokslutskommuniké 2019 |
2020-02-14 | - | Extra Bolagsstämma 2020 |
2019-10-23 | - | Kvartalsrapport 2019-Q3 |
2019-07-24 | - | Kvartalsrapport 2019-Q2 |
2019-05-07 | - | Split POLAR 16:1 |
2019-04-26 | - | Kvartalsrapport 2019-Q1 |
2019-03-19 | - | Årsstämma |
2019-02-04 | - | X-dag ordinarie utdelning POLAR 0.00 SEK |
2019-02-01 | - | Bokslutskommuniké 2018 |
Beskrivning
Land | Sverige |
---|---|
Lista | Spotlight |
Sektor | Hälsovård |
Industri | Medicinteknik |
Med-tech company PolarCool (publ.) expands its collaboration within the United Rugby Championship (URC), by signing an agreement with Dragons Rugby. The Welsh team becomes the seventh team in the URC to provide treatment with the PolarCap® System.
The current agreement between the URC and PolarCool includes the introduction of PolarCap® across the five nations of the URC. With the addition of Dragons Rugby, the teams providing concussion treatment with PolarCap® now include Dragons Rugby (Wales), Cardiff Rugby (Wales), Scarlets Rugby (Wales), Edinburgh Rugby (Scotland), Zebre Parma (Italy), Connacht Rugby (Ireland), and Vodacom Bulls (South Africa).
Erik Andersson, CEO of PolarCool, commented on the new partnership:
-We are pleased to welcome Dragons Rugby as PolarCap® providers in the United Rugby Championship. The positive feedback we continue to receive from teams currently using PolarCap® reinforces our commitment to the collaboration with URC. We are proud to together with URC work to improve player welfare and look forward to add more teams.
PolarCool and the URC are collectively aiming to conduct a large-scale scientific research project, which would involve a collaboration with additional rugby organizations such as World Rugby, along with leading global researchers in the field of sports science.
The United Rugby Championship is one of the world's most prestigious professional rugby leagues, featuring top teams from five international countries: Ireland, Italy, Scotland, South Africa, and Wales.
Erik Andersson - CEO PolarCool AB (publ.)
+46 - 738 60 57 00
E-mail: erik.andersson@polarcool.se